GMO's emerging market high-flyers

pg24-bill-jpg

Forget everything you know about investing in emerging markets, because at Boston-based investment firm GMO things work a little differently. Bill Nemerever and Tom Cooper, co-founders and co-managers of GMO's $5 billion emerging markets debt portfolio, don't travel to the countries they invest in. They avoid roadshows. They don't trust local currency bonds, even though most fund managers today think local debt is a hot opportunity.

"Roadshows are not very productive," says Cooper, 50. An avi

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: